Scientific resource
Blog
Blog
09/05/2023
Covalent drugs and the potential of benzoxaboroles
Molecules based on boron and benzoxaboroles are exciting as reversible covalent binders to target the serine and threonine proteome.
Blog
12/04/2023
Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis
In this blog, Pauline Bornert examines the current knowledge about pulmonary fibrosis, and preclinical options available to develop new therapeutic solutions.
Blog
02/02/2023
Why do preclinical cancer models still fail in the clinic?
We at Oncodesign Services strive to develop alternative Preclinical Cancer Models to better suit your drug development. Read more about our solutions here.
News
14/12/2022
Oncodesign Services looks to the future
As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future
Blog
08/11/2022
Why studying the gut microbes could help to cure?
We explore the importance of Gut Microbes on our health by discussing five of those Gut-Organ Axis - brain, intestine, liver, lung, and skin. Read more here.